A multinational study on motor function in early-onset FSHD

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Neurology

• Publication date

  2018-04-10

• Fields of study

  Medicine

• Identifiers
  DOI 10.1212/WNL.0000000000005297PMID 29540582PMCID PMC5894929
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Facioscapulohumeral Muscular Dystrophy.

  2018cited by this paper
• Reference values for developing responsive functional outcome measures across the lifespan

  2017cited by this paper
• Muscle MRI findings in facioscapulohumeral muscular dystrophy

  2016cited by this paper
• Clinical expression of facioscapulohumeral muscular dystrophy in carriers of 1–3 D4Z4 reduced alleles: experience of the FSHD Italian National Registry

  2016influential reference
• A novel clinical tool to classify facioscapulohumeral muscular dystrophy phenotypes

  2016cited by this paper
• Facioscapulohumeral dystrophy in children: design of a prospective, observational study on natural history, predictors and clinical impact (iFocus FSHD)

  2016cited by this paper
• Clinical trial preparedness in facioscapulohumeral muscular dystrophy: Clinical, tissue, and imaging outcome measures 29-30 May 2015, Rochester, New York.

  2016cited by this paper
• Mutations in DNMT3B Modify Epigenetic Repression of the D4Z4 Repeat and the Penetrance of Facioscapulohumeral Dystrophy.

  2016cited by this paper
• A cross sectional study of two independent cohorts identifies serum biomarkers for facioscapulohumeral muscular dystrophy (FSHD)

  2016cited by this paper
• Facioscapulohumeral muscular dystrophy.

  2015cited by this paper
• Individual epigenetic status of the pathogenic D4Z4 macrosatellite correlates with disease in facioscapulohumeral muscular dystrophy

  2015cited by this paper
• Inter-individual differences in CpG methylation at D4Z4 correlate with clinical variability in FSHD1 and FSHD2.

  2015cited by this paper
• Evidence-based guideline summary: Evaluation, diagnosis, and management of facioscapulohumeral muscular dystrophy

  2015cited by this paper
• Facioscapulohumeral Muscular Dystrophy As a Model for Epigenetic Regulation and Disease

  2014cited by this paper
• Upper Girdle Imaging in Facioscapulohumeral Muscular Dystrophy

  2014cited by this paper
• Risk of functional impairment in Facioscapulohumeral muscular dystrophy

  2014cited by this paper
• Population-based incidence and prevalence of facioscapulohumeral dystrophy

  2014cited by this paper
• Teaching Video NeuroImages: Beevor sign

  2013cited by this paper
• Large scale genotype–phenotype analyses indicate that novel prognostic tools are required for families with facioscapulohumeral muscular dystrophy

  2013cited by this paper
• Development of the Performance of the Upper Limb module for Duchenne muscular dystrophy

  2013cited by this paper
• Infantile facioscapulohumeral muscular dystrophy revisited: Expansion of clinical phenotypes in patients with a very short EcoRI fragment.

  2013cited by this paper
• Mutation spectrum and phenotypic manifestation in FSHD Greek patients.

  2012influential reference
• Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2

  2012cited by this paper
• A standardized clinical evaluation of patients affected by facioscapulohumeral muscular dystrophy: The FSHD clinical score

  2010cited by this paper
• Facioscapulohumeral muscular dystrophy: epidemiological and molecular study in a north‐east Italian population sample

  2009cited by this paper
• Facioscapulohumeral muscular dystrophy

  2006cited by this paper
• Severe phenotype in infantile facioscapulohumeral muscular dystrophy.

  2006cited by this paper
• The D4Z4 repeat-mediated pathogenesis of facioscapulohumeral muscular dystrophy.

  2005cited by this paper
• Height prediction from ulna length.

  2004cited by this paper
• Asymptomatic carriers and gender differences in facioscapulohumeral muscular dystrophy (FSHD).

  2004cited by this paper
• Clinical evaluator reliability for quantitative and manual muscle testing measures of strength in children

  2001cited by this paper
• A Prospective, Quantitative Study of the Natural History of Facioscapulohumeral Muscular Dystrophy (FSHD)

  1997cited by this paper
• Facioscapulohumeral muscular dystrophy (FSHD)

  1994cited by this paper
• De novo facioscapulohumeral muscular dystrophy defined by DNA probe p13E-11 (D4F104S1).

  1994cited by this paper
• Facioscapulohumeral muscular dystrophy in early childhood.

  1994cited by this paper
• FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated unit.

  1993cited by this paper
• Contractures in neuromuscular disease.

  1992cited by this paper
• Diagnostic criteria for facioscapulohumeral muscular dystrophy.

  1991cited by this paper
• Location of facioscapulohumeral muscular dystrophy gene on chromosome 4.

  1990cited by this paper
• Upper vs lower extremity functional loss in neuromuscular disease.

  1987cited by this paper
• Clinical trial in duchenne dystrophy. I. The design of the protocol

  1981cited by this paper
• Management of progressive muscular dystrophy in childhood.

  1963cited by this paper

• Framing childhood-onset facioscapulohumeral dystrophy: from first symptoms to future trials.

  2026cites this paper
• 279th ENMC international workshop: Classification, clinical care, outcome measures and biomarkers in childhood onset facioscapulohumeral dystrophy: towards standardizing clinical care and ensuring clinical trial readiness. Hoofddorp, The Netherlands, 1-3 November 2024.

  2025cites this paper
• Muscular Dystrophies.

  2025cites this paper
• Early-Onset Facial Weakness: Evaluation and Surgical Treatment of Facioscapulohumeral Muscular Disease.

  2025cites this paper
• Age at onset mediates genetic impact on disease severity in facioscapulohumeral muscular dystrophy.

  2024cites this paper
• Long-read Nanopore sequencing identified D4Z4 contractions in patients with facioscapulohumeral muscular dystrophy.

  2023cites this paper
• Systemic manifestations and symptom burden of facioscapulohumeral muscular dystrophy in a referral cohort

  2022cites this paper
• Pathomechanisms and biomarkers in facioscapulohumeral muscular dystrophy: roles of DUX4 and PAX7

  2021cites this paper
• Reliability and validity of the FSHD-composite outcome measure in childhood facioscapulohumeral dystrophy.

  2021cites this paper
• Natural History of Facioscapulohumeral Dystrophy in Children

  2021cites this paper
• Prevalence and disease progression of genetically-confirmed facioscapulohumeral muscular dystrophy type 1 (FSHD1) in China between 2001 and 2020: a nationwide population-based study

  2021cites this paper
• The “wrench-head” appearance of thigh muscle CT in infantile facioscapulohumeral muscular dystrophy

  2021cites this paper
• Natural History of Facioscapulohumeral Dystrophy in Children A 2-Year Follow-up

  2021cites this paper
• Phenotypic Variability Among Patients With D4Z4 Reduced Allele Facioscapulohumeral Muscular Dystrophy

  2020cites this paper
• Early-Onset Infantile Facioscapulohumeral Muscular Dystrophy: A Timely Review

  2020cites this paper
• A 5-year clinical follow-up study from the Italian National Registry for FSHD

  2020cites this paper
• Case Studies on the Genetic and Clinical Diagnosis of Facioscapulohumeral Muscular Dystrophy.

  2020cites this paper
• Multi-Omics Identifies Circulating miRNA and Protein Biomarkers for Facioscapulohumeral Dystrophy

  2020cites this paper
• Clinical and genetic features of somatic mosaicism in facioscapulohumeral dystrophy

  2020cites this paper
• Early onset facioscapulohumeral muscular dystrophy - Long-term follow-up of a patient with total facial diplegia.

  2019cites this paper
• Measurement properties and utility of performance-based outcome measures of physical functioning in individuals with facioscapulohumeral dystrophy - A systematic review and evidence synthesis.

  2019cites this paper
• Beatmung bei neuromuskulären Erkrankungen

  2019cites this paper
• Facioscapulohumeral Muscular Dystrophy: Update on Pathogenesis and Future Treatments

  2018cites this paper